Advanced delivery of biologics

Intellectual Property

Intellectual Property (IP) is a fundamental part of Arecor’s business consolidating its position as an industry leader in innovative formulation technology. Arecor’s patent families, which comprise 22 granted patents, broadly cover the following:

  • ArestatTM platform technologies (others are protected by know-how and trade secrets, including a proprietary computational algorithm)
  • Products:
    • Insulins
    • Glucagon
    • Blood Factors
    • Growth hormones
    • Vaccines

Arecor works in close coordination with its European and US patent advisors with specialist expertise in formulation patenting, to ensure robust and defensible claims.